Akademik Veri Yönetim Sistemi
PHYTOMEDICINE, cilt.149, ss.1-4, 2025 (SCI-Expanded, Scopus)
Over the last three decades, Phytomedicine has become a premier
journal in the realm of herbal medicine and plant-based therapies. As
editors of this journal, it is our immense pleasure to take a look back at
what has been achieved and also try to look into the future of the journal
and the entire scientific field of plant-based medicine with all its facets.
Founded in 1994 by Hildebert Wagner and Norman Farnsworth,
Phytomedicine was conceived as a journal focused on therapeutic applications,
specifically focusing on phytotherapy and phytopharmacology
spanning a broad range from complex herbal mixtures to single plant
extracts and isolated phytochemicals (Cock, 2011; Efferth et al., 2022).
At that time, the journal was published by Gustav Fischer Verlag, Jena,
Germany, and was later continued by Elsevier Publishing, Amsterdam,
Netherlands. Then, the journal was headed by Alexander Panossian,
who served as editor-in-chief from 2014 to 2017. Afterwards, Thomas
Efferth took over (Efferth, 2017). Phytomedicine is published in collaboration
with the European Scientific Cooperative on Phytotherapy
(ESCOP). The journal publishes in-depth research on plant-derived
medicines, including complex herbal formulations, plant extracts, and
isolated compounds, setting itself apart from other journals that
concentrate on broader natural products, phytochemistry, or complementary
and alternative medicine. Phytomedicine has been instrumental
in advancing techniques for the standardization and quality assurance of
herbal products, ensuring their safety, effectiveness, and reproducibility.
Consistent pharmacological activity and well-defined quality
standards for herbal preparations are seen as vital to integrating
plant-based treatments into mainstream healthcare. Its comprehensive
scope made Phytomedicine a platform for scientifically validating traditional
herbal practices, offering evidence of the potency, ha